Opko Health Inc.
06/15/2026 | Press release | Distributed by Public on 06/15/2026 07:01
Preclinical Data for OPKO Biologics' OPK8801001 in Acromegaly Presented at ENDO 2026
|
||||||||||||||||||||||||||||||
| Immediate Report | ||||||||||||||||||||||||||||||
| Regulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000 | ||||||||||||||||||||||||||||||
| References of previous documents relating to this matter(the reference does not constitute incorporation by reference): | ||||||||||||||||||||||||||||||
| Stock Exchange/Market: NASDAQ GSM | Date of revision of form structure: 06/08/2024 | |||||||||||||||||||||||||||||
| Address: Ashlegan 16 , Kiryat Gat8211804Israel , Tel: 08-9300051 , Fax: 08-9543101 | ||||||||||||||||||||||||||||||
| E-mail address: [email protected] Company site: Www.Opko.Com | ||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
| Previous names of reporting entity: | ||||||||||||||||||||||||||||||
|
|
||||||||||||||||||||||||||||||
| Name of the Signatory: Faibish Gabriel Position of Signatory in the reporting corporation: General Counsel Name of Employer Company: | ||||||||||||||||||||||||||||||
| Address: Ashlegan 16 , Kiryat Gat8211804Telephone: 08-9300051Facsimile: 08-9543101E-mail: [email protected] | ||||||||||||||||||||||||||||||
Opko Health Inc. published this content on June 15, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 15, 2026 at 13:01 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]